Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily A Hull-Ryde

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
ACS Infectious Diseases|July 6, 2016
Identification of small molecule inhibitors that block the <i>Toxoplasma gondii</i> rhoptry kinase ROP18Catherine Simpson, Nathaniel G Jones, Emily A Hull-Ryde, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
American Journal of Respiratory and Critical Care Medicine|April 12, 2019
XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway EpitheliaGang Chen, Carla M P Ribeiro, Ling Sun, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
ACS Infectious Diseases|July 6, 2016
Identification of small molecule inhibitors that block the <i>Toxoplasma gondii</i> rhoptry kinase ROP18Catherine Simpson, Nathaniel G Jones, Emily A Hull-Ryde, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
American Journal of Respiratory and Critical Care Medicine|April 12, 2019
XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway EpitheliaGang Chen, Carla M P Ribeiro, Ling Sun, et al.
Molecular Cancer Therapeutics|September 3, 2013
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivoSandra Christoph, Deborah Deryckere, Jennifer Schlegel, et al.
Pageof 2